Trials / Completed
CompletedNCT00503061
A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART
A Pharmaceopidemiological Study in Patients Who Use Symbicort Turbuhaler as Maintenance and Reliever Therapy (Symbicort SMART) Capturing Over Use and Under Use Via the General Practice Research Database
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To investigate how common it is that patients using Symibort SMART take high average daily doses that are not considered appropriate by their physician (overuse) or are hospitalised due to their asthma at least partly due to underuse.
Conditions
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2007-07-18
- Last updated
- 2010-12-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00503061. Inclusion in this directory is not an endorsement.